The diabetes market desperately needs a non-invasive glucose level monitor. A non-invasive device approved by CE and the FDA will be easily sold in very large quantities worldwide.

Other devices must be recalibrated every few hours or days. This is time-consuming and annoying. Our system only needs to be recalibrated every month and the process is very simple.

The human body is very complex and the accuracy levels required from blood glucose measurements must be very high. A single technology was not enough to create the necessary accuracy.

We realized there was an urgent need for such a product, and that it was a very large market, giving us all the reason in the world to work on it.

This is one of the most rapidly growing diseases in the world.

With careful and accurate monitoring, the patients can decide the optimal timing to take their medicine, or can refer themselves in time to a doctor if the results show an aggravation or deterioration in condition.